ADOLESCENT;
ADULT;
ARTICLE;
COMORBIDITY;
CONSULTATION;
DRUG EFFICACY;
DRUG INDICATION;
DRUG INFORMATION;
DRUG LABELING;
DRUG USE;
FEMALE;
FREQUENCY ANALYSIS;
HEALTH SURVEY;
HOSPITAL PATIENT;
HUMAN;
INTELLECTUAL IMPAIRMENT;
INTERNATIONAL CLASSIFICATION OF DISEASES;
LICENSING;
MAJOR CLINICAL STUDY;
MALE;
MENTAL DISEASE;
MENTAL HEALTH CARE;
PATIENT EDUCATION;
PRESCRIPTION;
PSYCHIATRIST;
ADOLESCENT;
ADULT;
BORDERLINE PERSONALITY DISORDER;
CHILD;
COMORBIDITY;
CROSS-SECTIONAL STUDIES;
DRUG APPROVAL;
DRUG THERAPY, COMBINATION;
FEMALE;
HEALTH KNOWLEDGE, ATTITUDES, PRACTICE;
HEALTH SURVEYS;
HOSPITALS, PSYCHIATRIC;
HUMANS;
MALE;
MENTAL DISORDERS;
MENTAL RETARDATION;
PATIENT ADMISSION;
PATIENT EDUCATION;
PRESCRIPTIONS, DRUG;
PSYCHOTIC DISORDERS;
PSYCHOTROPIC DRUGS;
Reducing antipsychotic medication in people with a learning disability
Ahmed Z., Fraser W., Kerr M. P., Kiernan C., Emerson E., Robertson J., Felce D., Allen D., Baxter H. & Thomas J. (2000) Reducing antipsychotic medication in people with a learning disability. British Journal of Psychiatry 176, 42-6.
Association of the British Pharmaceutical Industry Datapharm Communications Ltd, Epsom, UK
Association of the British Pharmaceutical Industry (2004) Medicines Compendium 2004. Datapharm Communications Ltd, Epsom, UK.
(2004)
4
0029817887
Factors associated with the successful or unsuccessful withdrawal of antipsychotic drug therapy prescribed for people with learning disabilities
Branford D. (1996) Factors associated with the successful or unsuccessful withdrawal of antipsychotic drug therapy prescribed for people with learning disabilities. Journal of Intellectual Disability Research 40, 322-9.
British Medical Association and Royal Pharmaceutical Society of Great Britain British National Formulary No. 48. British Medical Association and Royal Pharmaceutical Society of Great Britain, London
British Medical Association and Royal Pharmaceutical Society of Great Britain (2004) British National Formulary No. 48. British Medical Association and Royal Pharmaceutical Society of Great Britain, London.
(2004)
6
0032700378
Antipsychotic medication challenging behaviour in people with learning disability: A systematic review of randomised controlled trials
Brylewski J. & Duggan L. (1999) Antipsychotic medication challenging behaviour in people with learning disability: a systematic review of randomised controlled trials. Journal of Intellectual Disability Research 43, 360-71.
The use of unlicensed medicines or licensed medicines for unlicensed applications in paediattic practice
Royal College of Paediatrics and Child Health/Neonatal & Paediatric Pharmacists Group Standing Committee on Medicines Retrieved December, 2004, from:
Royal College of Paediatrics and Child Health/Neonatal & Paediatric Pharmacists Group Standing Committee on Medicines (2000) The use of unlicensed medicines or licensed medicines for unlicensed applications in paediattic practice. Retrieved December, 2004, from: http://www.rcpch.ac.uk/publications/formulary_medicines.html
(2000)
15
11844269286
Withdrawal of antipsychotic drugs from adults with intellectual disabilities
Stevenson C., Rajan L., Reid G., Melville C., McGilp R. & Cooper S. A. (2004) Withdrawal of antipsychotic drugs from adults with intellectual disabilities. Irish Journal of Psychological Medicine 21, 85-90.
World Health Organization Clinical descriptions and diagnostic guidelines. WHO, Geneva
World Health Organization (1992) The ICD-10 Classification of Mental and Behavioural Disorders. Clinical descriptions and diagnostic guidelines. WHO, Geneva.
